Rituximab as a maintenance treatment in patients with pemphigus vulgaris: When is the right time for discontinuation?

Rituximab as a maintenance treatment in patients with pemphigus vulgaris: When is the right time for discontinuation?

DATA AVAILABILITY STATEMENT The data that support the findings of this study are available from the corresponding author upon reasonable request. The protocol of study was approved by ethics committee of Tehran University of Medical Sciences. Rituximab and risk of second primary malignancies in pati...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of cosmetic dermatology 2024-02, Vol.23 (2), p.406-408
Hauptverfasser: Aryanian, Zeinab, Balighi, Kamran, Emadi, Seyed Naser, Hatami, Parvaneh
Format: Artikel
Sprache:eng
Schlagworte:
Arthritis
Case reports
Humans
Immunologic Factors - therapeutic use
Immunotherapy
Lymphoma
Monoclonal antibodies
Pemphigus - diagnosis
Pemphigus - drug therapy
Rituximab - therapeutic use
Targeted cancer therapy
Treatment Outcome
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:DATA AVAILABILITY STATEMENT The data that support the findings of this study are available from the corresponding author upon reasonable request. The protocol of study was approved by ethics committee of Tehran University of Medical Sciences. Rituximab and risk of second primary malignancies in patients with non‐Hodgkin lymphoma: a systematic review and meta‐analysis.
ISSN:1473-2130
1473-2165
DOI:10.1111/jocd.16030